Article Information
History
- November 3, 2022.
Article Versions
- Version 1 (August 2, 2022 - 06:19).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Joseph A. Lewnard1,2,3,*,
- Vennis Hong4,
- Jeniffer S. Kim4,
- Sally F. Shaw4,
- Bruno Lewin4,
- Harpreet Takhar4 and
- Sara Y. Tartof4,5,*
- 1Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, California 94720, United States
- 2Division of Infectious Diseases & Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California 94720, United States
- 3Center for Computational Biology, College of Engineering, University of California, Berkeley, Berkeley, California 94720, United States
- 4Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California 91101, United States
- 5Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California 91101, United States
- ↵*Addresses for correspondence: Joseph A. Lewnard, 2121 Berkeley Way, Berkeley, California 94720, jLewnard{at}berkeley.edu, 510-664-4050, Sara Y. Tartof, 100 South Los Robles, Pasadena, California 91101, Sara.Y.Tartof{at}kp.org, 626-564-3001
Posted November 03, 2022.
Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
2
Blogs/Media
Author Videos